Fengmin Shao

868 total citations
36 papers, 471 citations indexed

About

Fengmin Shao is a scholar working on Molecular Biology, Infectious Diseases and Nephrology. According to data from OpenAlex, Fengmin Shao has authored 36 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Infectious Diseases and 7 papers in Nephrology. Recurrent topics in Fengmin Shao's work include COVID-19 Clinical Research Studies (5 papers), Renal cell carcinoma treatment (4 papers) and Chronic Kidney Disease and Diabetes (4 papers). Fengmin Shao is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), Renal cell carcinoma treatment (4 papers) and Chronic Kidney Disease and Diabetes (4 papers). Fengmin Shao collaborates with scholars based in China, United States and Australia. Fengmin Shao's co-authors include Lei Yan, Yue Gu, Huixia Cao, Xu Dong Zhang, Mian Wu, Rick F. Thorne, Jianqin Gu, Lirong Zhang, Wenwen Zhang and Ruijie Wang and has published in prestigious journals such as JAMA, Blood and PLoS ONE.

In The Last Decade

Fengmin Shao

32 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengmin Shao China 14 183 95 72 65 58 36 471
Bili Zhang China 11 128 0.7× 56 0.6× 47 0.7× 64 1.0× 116 2.0× 45 486
Jalal Etemadi Iran 12 96 0.5× 57 0.6× 122 1.7× 88 1.4× 36 0.6× 52 462
Jie You China 11 203 1.1× 132 1.4× 21 0.3× 28 0.4× 43 0.7× 23 429
Lihua Wang China 11 169 0.9× 93 1.0× 121 1.7× 105 1.6× 13 0.2× 37 569
Yıldız Okuturlar Türkiye 13 103 0.6× 72 0.8× 48 0.7× 70 1.1× 31 0.5× 55 475
Alfonso Amore Italy 16 99 0.5× 78 0.8× 23 0.3× 64 1.0× 43 0.7× 38 580
Fengfeng Xu China 9 138 0.8× 36 0.4× 169 2.3× 63 1.0× 38 0.7× 11 416
Takeshi Fujita Japan 12 97 0.5× 30 0.3× 86 1.2× 68 1.0× 21 0.4× 47 421
Dehong Wu China 11 164 0.9× 42 0.4× 21 0.3× 103 1.6× 178 3.1× 27 529

Countries citing papers authored by Fengmin Shao

Since Specialization
Citations

This map shows the geographic impact of Fengmin Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengmin Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengmin Shao more than expected).

Fields of papers citing papers by Fengmin Shao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengmin Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengmin Shao. The network helps show where Fengmin Shao may publish in the future.

Co-authorship network of co-authors of Fengmin Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Fengmin Shao. A scholar is included among the top collaborators of Fengmin Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengmin Shao. Fengmin Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lin, Tao, Xiaoling Zhang, Xuegang Niu, et al.. (2025). Efficacy and safety of telitacicept in the treatment of IgA nephropathy: a single-center, real-world study. Frontiers in Pharmacology. 16. 1642137–1642137.
3.
Sun, Xuefeng, Li Zhang, Hongli Lin, et al.. (2025). Randomized Trial of Lower-Dose Roxadustat Efficacy and Safety in Non–Dialysis-Dependent CKD-Associated Anemia. Kidney International Reports. 10(4). 1050–1062. 1 indexed citations
4.
Wang, Shasha, Yue Zhang, Xin Jiang, et al.. (2024). The FGF23–Klotho axis promotes microinflammation in chronic kidney disease. Cytokine. 184. 156781–156781. 4 indexed citations
5.
Wang, Ning, Yifeng Hu, Shasha Wang, et al.. (2024). Development of a novel disulfidptosis-related lncRNA signature for prognostic and immune response prediction in clear cell renal cell carcinoma. Scientific Reports. 14(1). 624–624. 3 indexed citations
6.
Wang, Luoyi, Zhaomin Mao, Lirong Zhang, & Fengmin Shao. (2024). Molecular Pathogenic Mechanisms of IgA Nephropathy Secondary to COVID-19 mRNA Vaccination. Kidney & Blood Pressure Research. 49(1). 144–154. 2 indexed citations
7.
8.
Wang, Ruijie, Rick F. Thorne, Xu Dong Zhang, et al.. (2021). LncRNA GIRGL drives CAPRIN1-mediated phase separation to suppress glutaminase-1 translation under glutamine deprivation. Science Advances. 7(13). 66 indexed citations
9.
Bai, Yan, Junling Xu, Lijuan Chen, et al.. (2021). Inflammatory response in lungs and extrapulmonary sites detected by [18F] fluorodeoxyglucose PET/CT in convalescing COVID-19 patients tested negative for coronavirus. European Journal of Nuclear Medicine and Molecular Imaging. 48(8). 2531–2542. 27 indexed citations
10.
Wu, Xiaoqiang, Zhiwei Wang, Junpeng Wang, et al.. (2021). Exosomes Secreted by Mesenchymal Stem Cells Induce Immune Tolerance to Mouse Kidney Transplantation via Transporting LncRNA DANCR. Inflammation. 45(1). 460–475. 25 indexed citations
11.
Zhu, Guodong, Jing Yu, Yan Chen, et al.. (2021). Genome-wide CRISPR/Cas9 screening identifies CARHSP1 responsible for radiation resistance in glioblastoma. Cell Death and Disease. 12(8). 724–724. 20 indexed citations
12.
Li, Deyu, Lianyuan Tao, Fengmin Shao, et al.. (2021). Clinical features and prognostic factors of patients with metastatic renal cell carcinoma stratified by age. Aging. 13(6). 8290–8305. 8 indexed citations
13.
Zheng, Yan, Yibo Wen, Huixia Cao, et al.. (2021). Global Characterization of Immune Infiltration in Clear Cell Renal Cell Carcinoma. OncoTargets and Therapy. Volume 14. 2085–2100. 14 indexed citations
14.
Khan, Muhammad Riaz, Xu Dong Zhang, Jingmin Li, et al.. (2021). lncRNA TRMP-S directs dual mechanisms to regulate p27-mediated cellular senescence. Molecular Therapy — Nucleic Acids. 24. 971–985. 13 indexed citations
15.
Zhang, Weifeng, Yan Bai, Kyongtae Ty Bae, et al.. (2020). FDG PET/CT evaluation of a patient recovering from COVID-19. European Journal of Nuclear Medicine and Molecular Imaging. 47(11). 2703–2705. 8 indexed citations
16.
Zhu, Yanyan, Shundong Cang, Bowang Chen, et al.. (2020). Patient Stratification of Clear Cell Renal Cell Carcinoma Using the Global Transcription Factor Activity Landscape Derived From RNA-Seq Data. Frontiers in Oncology. 10. 526577–526577. 8 indexed citations
17.
Cao, Huixia, et al.. (2020). MicroRNA-10a-3p mediates Th17/Treg cell balance and improves renal injury by inhibiting REG3A in lupus nephritis. International Immunopharmacology. 88. 106891–106891. 23 indexed citations
18.
Jiao, Xiaojing, Dong Zhang, Quan Hong, et al.. (2019). Netrin-1 works with UNC5B to regulate angiogenesis in diabetic kidney disease. Frontiers of Medicine. 14(3). 293–304. 18 indexed citations
19.
Yan, Sijia, Fengmin Shao, Wen Zhang, et al.. (2018). HLA-C*12:02 is strongly associated with Xuesaitong-induced cutaneous adverse drug reactions. The Pharmacogenomics Journal. 19(3). 277–285. 5 indexed citations
20.
Fan, Xiaoguang, Rong Huang, Juan Wang, et al.. (2014). Risk Factors for the First Episode of Peritonitis in Southern Chinese Continuous Ambulatory Peritoneal Dialysis Patients. PLoS ONE. 9(9). e107485–e107485. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bili Zhang Breakdown of academic impact, for papers by Jalal Etemadi Breakdown of academic impact, for papers by Jie You Breakdown of academic impact, for papers by Lihua Wang Breakdown of academic impact, for papers by Yıldız Okuturlar Breakdown of academic impact, for papers by Alfonso Amore Breakdown of academic impact, for papers by Fengfeng Xu Breakdown of academic impact, for papers by Takeshi Fujita Breakdown of academic impact, for papers by Dehong Wu
Rankless by CCL
2026